Ignite Creation Date:
2025-12-25 @ 3:09 AM
Ignite Modification Date:
2025-12-31 @ 10:40 PM
Study NCT ID:
NCT04380805
Status:
COMPLETED
Last Update Posted:
2025-02-28
First Post:
2020-05-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of AK104, a PD-1/CTLA-4 Bispecific Antibody in Subjects With Recurrent/Metastatic Cervical Cancer
Sponsor:
Akeso
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-07-15
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-31
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-01
First Submit QC Date:
None
Study First Post Date:
2020-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-26
Last Update Post Date:
2025-02-28
Last Update Post Date Type:
ACTUAL